Phase II study of chemoselection with docetaxel plus 5-fluorouracil and cisplatin induction chemotherapy and subsequent conversion surgery for locally advanced unresectable esophageal cancer

被引：0
|
作者：
Yokota, Tomoya
Kato, Ken
Hamamoto, Yasuo
Tsubosa, Yasuhiro
Ogawa, Hirofumi
Ito, Yoshinori
Hara, Hiroki
Ura, Takashi
Kojima, Takashi
Chin, Keisho
Hironaka, Shuichi
Kii, Takayuki
Kojima, Yasushi
Akutsu, Yasunori
Matsushita, Hisayuki
Kawakami, Kentaro
Mori, Keita
Nagai, Yushi
Asami, Chika
Kitagawa, Yuko
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.4021
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4021
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer
    Tomoya Yokota
    Ken Kato
    Yasuo Hamamoto
    Yasuhiro Tsubosa
    Hirofumi Ogawa
    Yoshinori Ito
    Hiroki Hara
    Takashi Ura
    Takashi Kojima
    Keisho Chin
    Shuichi Hironaka
    Takayuki Kii
    Yasushi Kojima
    Yasunori Akutsu
    Hisayuki Matsushita
    Kentaro Kawakami
    Keita Mori
    Yushi Nagai
    Chika Asami
    Yuko Kitagawa
    [J]. British Journal of Cancer, 2016, 115 : 1328 - 1334
  • [2] Phase II study of chemoselection with docetaxel plus cisplatin and 5-fluorouracil induction chemotherapy and subsequent conversion surgery for locally advanced unresectable oesophageal cancer
    Yokota, Tomoya
    Kato, Ken
    Hamamoto, Yasuo
    Tsubosa, Yasuhiro
    Ogawa, Hirofumi
    Ito, Yoshinori
    Hara, Hiroki
    Ura, Takashi
    Kojima, Takashi
    Chin, Keisho
    Hironaka, Shuichi
    Kii, Takayuki
    Kojima, Yasushi
    Akutsu, Yasunori
    Matsushita, Hisayuki
    Kawakami, Kentaro
    Mori, Keita
    Nagai, Yushi
    Asami, Chika
    Kitagawa, Yuko
    [J]. BRITISH JOURNAL OF CANCER, 2016, 115 (11) : 1328 - 1334
  • [3] Long-Term Outcome of Patients with Locally Advanced Clinically Unresectable Esophageal Cancer Undergoing Conversion Surgery after Induction Chemotherapy with Docetaxel Plus Cisplatin and 5-Fluorouracil
    Abe, Tetsuya
    Higaki, Eiji
    Hosoi, Takahiro
    Nagao, Takuya
    Bando, Hideaki
    Kadowaki, Shigenori
    Muro, Kei
    Tanaka, Tsutomu
    Tajika, Masahiro
    Niwa, Yasumasa
    Shimizu, Yasuhiro
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (02) : 712 - 721
  • [4] Long-Term Outcome of Patients with Locally Advanced Clinically Unresectable Esophageal Cancer Undergoing Conversion Surgery after Induction Chemotherapy with Docetaxel Plus Cisplatin and 5-Fluorouracil
    Tetsuya Abe
    Eiji Higaki
    Takahiro Hosoi
    Takuya Nagao
    Hideaki Bando
    Shigenori Kadowaki
    Kei Muro
    Tsutomu Tanaka
    Masahiro Tajika
    Yasumasa Niwa
    Yasuhiro Shimizu
    [J]. Annals of Surgical Oncology, 2021, 28 : 712 - 721
  • [5] Phase II Study of Docetaxel, Cisplatin, and 5-Fluorouracil Chemoradiotherapy for Unresectable Esophageal Cancer
    Takahashi, Kosuke
    Osaka, Yoshiaki
    Ota, Yoshihiro
    Watanabe, Takafumi
    Iwasaki, Kenichi
    Tachibana, Shingo
    Nagakawa, Yuichi
    Katsumata, Kenji
    Tsuchida, Akihiko
    [J]. ANTICANCER RESEARCH, 2020, 40 (05) : 2827 - 2832
  • [6] Phase II Study of Docetaxel and Cisplatin Chemotherapy in 5-Fluorouracil/Cisplatin Pretreated Esophageal Cancer
    Shim, Hyun-Jeong
    Cho, Sang-Hee
    Hwang, Jun-Eul
    Bae, Woo-Kyun
    Song, Sang-Yun
    Cho, Sung-Bum
    Lee, Wan-Sik
    Joo, Young-Eun
    Na, Kook-Joo
    Chung, Ik-Joo
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (06): : 624 - 628
  • [7] Induction chemoradiotherapy including docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal cancer
    Masashi Hashimoto
    Yasuhiro Shirakawa
    Naoaki Maeda
    Shunsuke Tanabe
    Kazuhiro Noma
    Kazufumi Sakurama
    Kuniaki Katsui
    Masahiko Nishizaki
    Toshiyoshi Fujiwara
    [J]. Esophagus, 2020, 17 : 127 - 134
  • [8] Induction chemoradiotherapy including docetaxel, cisplatin, and 5-fluorouracil for locally advanced esophageal cancer
    Hashimoto, Masashi
    Shirakawa, Yasuhiro
    Maeda, Naoaki
    Tanabe, Shunsuke
    Noma, Kazuhiro
    Sakurama, Kazufumi
    Katsui, Kuniaki
    Nishizaki, Masahiko
    Fujiwara, Toshiyoshi
    [J]. ESOPHAGUS, 2020, 17 (02) : 127 - 134
  • [9] Neoadjuvant chemotherapy for locally advanced esophageal cancer comparing cisplatin and 5-fluorouracil versus docetaxel plus cisplatin and 5-fluorouracil: a propensity score matching analysis
    Nishiwaki, Noriyuki
    Noma, Kazuhiro
    Kunitomo, Tomoyoshi
    Hashimoto, Masashi
    Maeda, Naoaki
    Tanabe, Shunsuke
    Sakurama, Kazufumi
    Shirakawa, Yasuhiro
    Fujiwara, Toshiyoshi
    [J]. ESOPHAGUS, 2022, 19 (04) : 626 - 638
  • [10] Neoadjuvant chemotherapy for locally advanced esophageal cancer comparing cisplatin and 5-fluorouracil versus docetaxel plus cisplatin and 5-fluorouracil: a propensity score matching analysis
    Noriyuki Nishiwaki
    Kazuhiro Noma
    Tomoyoshi Kunitomo
    Masashi Hashimoto
    Naoaki Maeda
    Shunsuke Tanabe
    Kazufumi Sakurama
    Yasuhiro Shirakawa
    Toshiyoshi Fujiwara
    [J]. Esophagus, 2022, 19 : 626 - 638
12345